US Patent 10676526 FcRn antibodies and methods of use thereof
Patent 10676526 was granted and assigned to Momenta Pharmaceuticals on June, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 29, 2016
0
Date of Patent
June 9, 2020
0
Patent Applicant
Patent Application Number
15546870
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10676526 FcRn antibodies and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
